Alcon LenSx, Inc.

What Alcon LenSx, Inc. does

Alcon LenSx, Inc. operates as part of Alcon Inc. (NYSE: ALC), a global eye care company headquartered in Fort Worth, Texas, whose US professional operations are directed from Aliso Viejo, California. The company develops and manufactures a broad portfolio of ophthalmic products across four pillars: contact lenses (daily, weekly, and monthly replacement lenses built on proprietary Water Gradient, CELLIGENT, ACTIV-FLO, and SMARTSURFACE technologies), surgical equipment and intraocular lenses for cataract, refractive, and vitreoretinal surgery (including the NGENUITY 3D Visualization System, CENTURION phaco system, ARGOS biometer, Clareon IOLs, and Wavelight refractive lasers), dry eye and ocular surface products (the Systane family plus the iLux2 thermal pulsation device for meibomian gland dysfunction), and prescription pharmaceuticals for ocular conditions.

Underlying technology is anchored in proprietary surface chemistry and optical designs that are difficult for competitors to replicate, complemented by digital surgical visualization, biometric IOL planning, and disposable instrumentation (GRIESHABER DSP, FINESSE REFLEX). The business model is a hybrid of hardware sales (surgical capital and consumables, contact lenses), pharmaceutical prescription sales, and recurring patient-level consumables (eye drops, contact lens reorders). Multi-channel distribution serves eye care professionals through field sales, the MyAlcon professional portal, and the Adi Online Store, while patients are reached via eye care professionals, the Marlo reordering platform, the MyAlcon Store app, and affordability programs such as the BlinkRx copay partnership. Customers are split across eye care professionals (optometrists and ophthalmologists), ambulatory surgery centers and hospitals, and end patients; the company bills primarily on a unit/shipment basis with pricing negotiated by ECPs and influenced by insurance coverage and manufacturer rebates.

The company is actively operating with a diversified global sub-brand portfolio (17+ sub-brands including TOTAL30, PRECISION1, PRECISION7, Systane, Clareon, NGENUITY, Wavelight, GenTeal, Marlo, and Clear Care), ongoing product expansion (2024 PRECISION7 launch; 2026 parameter expansions for astigmatism SKUs), and an integrated digital ecosystem that includes the Alcon Experience Academy for clinical training. Founded in 1945 and spun off from Novartis as an independent public company in 2019, Alcon Inc. maintains multiple wholly-owned operating subsidiaries serving distinct professional, educational, and patient-facing functions.

Name

Alcon LenSx, Inc.

Legal name

Alcon Inc.

Website

https://myalcon.com

Company type

Public

Founded year

1945

Operating status

Operating

Headcount range

251–500 employees

Short description

Alcon LenSx, Inc. operates as part of Alcon Inc., a global eye care company that develops contact lenses, cataract and vitreoretinal surgical equipment, intraocular lenses, dry eye treatments, and ocular pharmaceuticals sold to eye care professionals, surgery centers, and patients worldwide.

Ownership category

akta.pro rank

Headquarters

HQ city

Aliso Viejo

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Operations

Revenue model

1. Medical Device and Surgical Equipment Sales: Alcon generates revenue primarily through the sale of eye care products including surgical equipment and devices, contact lenses (daily, weekly, monthly, and specialty lenses), eye drops and dry eye treatments, prescription drugs, and contact lens solutions. Products are sold through direct sales, online stores (MyAlcon, Adi Online Store, Marlo), and distribution channels to eye care professionals and patients.
2. Prescription Pharmaceutical Products: Sale of prescription pharmaceutical products for eye conditions including dry eye, glaucoma, allergy, and post-surgical care, sold to patients through pharmacies and healthcare providers.
3. Patient Affordability Programs: Patient affordability programs including copay assistance and manufacturer rebates drive adoption of prescription and OTC eye care products. Alcon offers copay cards and patient assistance programs to reduce out-of-pocket costs for eligible patients.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels5 records

Core offering

Alcon LenSx, Inc. develops, manufactures and distributes ophthalmic medical devices and eye care products spanning contact lenses (PRECISION1 daily, PRECISION7 weekly, TOTAL30 monthly families), intraocular lenses (Clareon family), cataract and vitreoretinal surgical equipment and instruments (NGENUITY 3D Visualization System, LuxOR Revalia microscope, CENTURION phaco system, GRIESHABER DSP and FINESSE REFLEX instruments, Wavelight refractive lasers), dry eye treatments and devices (Systane, GenTeal, Systane iLux2), prescription ocular drugs, and contact lens care solutions (Clear Care, Opti-Free). The company sells primarily to eye care professionals, ambulatory surgery centers and hospitals, with complementary direct-to-patient ordering enabled through MyAlcon, Marlo and BlinkRx.

Product overview

Alcon is a leading eye care company offering a comprehensive portfolio of products across contact lenses, surgical equipment, dry eye treatments, and prescription medications. The contact lens portfolio includes daily disposables (PRECISION1), weekly (PRECISION7), and monthly (TOTAL30 family) options with Water Gradient and CELLIGENT technologies. Surgical offerings feature the NGENUITY 3D Visualization System, FINESSE instruments, and LuxOR microscopes. Dry eye treatments span Systane and GenTeal product families plus the iLux2 MGD treatment device. The company provides digital platforms including MyAlcon for professionals and Marlo for patient engagement, supported by patient assistance programs like BlinkRx.

Differentiator

Problem solved

Functional benefit

Brands

• TOTAL30: Monthly replacement Water Gradient contact lenses featuring CELLIGENT Technology for comfort and deposit resistance
• PRECISION1
• PRECISION7
• SYSTANE
• GenTeal
• Clareon
• NGENUITY 3D
• Systane iLux2
• Wavelight
• ARGOS
• CENTURION
• Grieshaber DSP
• Clear Care
• Opti-Free
• Marlo
• Alcon Experience Academy
• ICAPS

Products and services

• PRECISION1 Daily disposable silicone hydrogel contact lens with SMARTSURFACE Technology featuring greater than 80% water content at the outer surface, designed for new wearers to help prevent lens dropout, available in sphere and toric (astigmatism) variants.
• PRECISION7 One-week replacement silicone hydrogel contact lens featuring ACTIV-FLO System sustained-release technology that delivers comfort and precise vision through the full replacement cycle, even on day 7.
• TOTAL30 First and only monthly replacement Water Gradient contact lens featuring Water Gradient Technology (55% water at core to nearly 100% at the outer surface) and CELLIGENT Technology biomimetic surface that resists bacteria and lipid deposits.
• TOTAL30 for Astigmatism Monthly replacement Water Gradient toric contact lens combining Water Gradient and CELLIGENT Technologies with PRECISION BALANCE 8|4 lens design; covers 99% of astigmatic eyes across 5,490 parameters.
• TOTAL30 Multifocal Monthly replacement multifocal contact lens with Water Gradient and CELLIGENT Technologies and PRECISION PROFILE lens design for seamless vision from near through far; #1 selling multifocal contact lens design in the U.S.
• TOTAL30 Multifocal for Astigmatism Alcon's first multifocal toric contact lens combining Water Gradient and CELLIGENT Technologies for astigmatic presbyopes, delivering end-of-day comfort through day 30.
• Clear Care Hydrogen peroxide-based cleaning and disinfecting solution for soft contact lenses, sold through eye care professionals and retail channels.
• Opti-Free Multi-purpose disinfecting contact lens solution portfolio including OPTI-FREE Replenish and puremoist formulations, plus companion rewetting drops, sold through eye care professionals and retail channels.
• Systane Family of Products Complete family of dry eye relief products including Systane Complete PF, Systane Hydration PF, Systane Ultra, Systane Balance, Systane Gel Drops, Systane Nighttime Ointment, and Systane Zaditor for allergy relief; the #1 doctor recommended brand for dry eye.
• Systane iLux2 All-in-one portable thermal pulsation device for evaluating and treating meibomian gland dysfunction (MGD) in-office via customizable heat and expression therapy, with HD video replay and gland imaging for patient education.
• GenTeal Tears Family of lubricant eye drops for fast dry eye symptom relief, including Mild, Moderate, and Severe formulations plus preservative-free options and gel/ointment variants.
• NGENUITY 3D Visualization System Digital 3D stereoscopic high-definition surgical visualization system for ophthalmic surgery, providing up to 5x extended depth of field, 48% increased magnification, and 42% increased depth resolution compared with analog microscopes, with multiple digital image guidance modes and Alcon surgical platform integration.
• FINESSE REFLEX Handle (GRIESHABER DSP Instrumentation) Single-use vitreoretinal microinstrument handle for ophthalmic surgery, featuring expanded extraocular working space, optimized contact and broad maneuverability; part of the GRIESHABER DSP instrumentation line.
• LuxOR Revalia Ophthalmic Microscope Ophthalmic surgical microscope providing enhanced visualization for cataract and vitreoretinal surgery.
• MyAlcon Professional Portal Professional digital portal for U.S. eye care practitioners providing applications, online ordering, account management, fitting guides, clinical articles and practice tools including MyAlcon FittingHub.
• Marlo Patient Reordering Platform Patient-facing digital platform that enables contact lens reordering 24/7 with home delivery while keeping reorders routed to the prescribing practice.

Quantifiable outcome

• 96% fit success for TOTAL30 Multifocal contact lenses with two lenses or less at initial fitting
• +8 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature9 records

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Johnson & Johnson Vision: Operates the Acuvue contact lens franchise (dailies, two-week, multifocal, toric) and cataract surgical products. Direct competitor across Alcon's contact lens and surgical vision categories serving the same ECP and patient base.
• Bausch + Lomb: Portfolio spans contact lenses (Biotrue, Ultra), lens care solutions, intraocular lenses, and dry eye/vitreoretinal surgical products. Direct peer across Alcon's consumer lens, lens care, and surgical vision franchises.
• CooperVision: A major global contact lens manufacturer (clariti, MyDay, Biofinity, MiSight) competing head-to-head in daily, monthly, toric, and myopia-control contact lenses against Alcon's PRECISION1, TOTAL30, and PRECISION7 families.
• HOYA Corporation: Surgical optics business manufactures IOLs (including trifocal/EDOF), IOL injectors, and intraocular gases. Direct competitor to Alcon's Clareon PanOptix Pro trifocal IOL and cataract surgical equipment.

Broad incumbents

• Carl Zeiss Meditec: A broader ophthalmic incumbent offering surgical microscopes, IOLs (AT LISA tri/EDOF), laser systems, and diagnostics—competing with Alcon's NGENUITY, Clareon, Wavelight, and IOL product lines across the cataract/refractive surgical value chain.
• Topcon Corporation: Broad ophthalmic equipment portfolio (OCT, fundus imaging, surgical) that competes with Alcon's diagnostic, refractive, and surgical visualization offerings, though Topcon does not directly compete in contact lenses.

Emerging players

• STAAR Surgical: Specializes in phakic ICL refractive lenses and IOLs, overlapping with Alcon's refractive surgery and premium IOL franchises. A more focused, emerging challenger with overlap in cataract/refractive vision correction.
• Glaukos Corporation: Focused on MIGS (minimally invasive glaucoma surgery) devices (iStent), competing with Alcon's glaucoma surgical offering. Overlaps only on the glaucoma surgery adjacency—not contact lens or cataract consumables.
• SightGlass Vision: Specializes in spectacle lenses for myopia management, an emerging channel targeting the same Gen Z/myopia-control cohort Alcon is recruiting. Indirect competitive overlap through contact lens vs spectacle lens mix.

Others

• Warby Parker: Direct-to-consumer optical retailer with prescription eyewear, contacts, and eye exams; an adjacent operator that competes for patient wallet share and threatens the ECP-led dispensing model Alcon relies on for premium lens adoption.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/truevision-systems

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Alcon LenSx, Inc.